Fluticasone propionate inhalation - Teva Pharmaceutical Industries

Drug Profile

Fluticasone propionate inhalation - Teva Pharmaceutical Industries

Alternative Names: ArmonAirTM RespiClick; Fluticasone propionate MDPI; Fluticasone propionate MDPI - Teva Pharmaceutical Industries; Fluticasone propionate RespiClick®

Latest Information Update: 12 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Analgesics; Androstadienes; Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists; Lipocortin synthesis agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 06 Mar 2017 Updated efficacy data from a phase III trial in Asthma presented at the 2017 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI-2017)
  • 30 Jan 2017 Registered for Asthma (In adolescents, In adults) in USA (Inhalation)
  • 01 Dec 2016 Phase-III clinical trials in Asthma (In children) in USA (Inhalation) (NCT02980133)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top